This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Stocks Hitting New 52-Week Highs


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Medivation (MDVN - Get Report) is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases, for which there are limited treatment options. This stock is trading up 1.55% to $46.66 in recent trading after hitting a 52-week high of $46.73 earlier in the day.

Today's Range: $45.38-$46.73

52-week Range: $11.16-$46.73

Volume: 192,000

Three-Month Average Volume: 904,471

Medivation has a market cap of $1.61 billion and an enterprise value of $1.44 billion. This stock trades at a price-to-sales of 25.84. Its estimated growth rate for this year is 2%, and for next year it's pegged at 30.9%. The current short interest as a percentage of the float for Medivation is rather high at 7.5%.

From a technical standpoint, this is in full breakout mode now that it has cleared some past overhead resistance at $44.93.

I could see this stock tagging $50 a share in the coming weeks, but traders should be careful since shares of MDVN are hitting overbought levels. The current RSI reading is at 80.59, which indicates an extreme overbought condition for any stock.

Medivation shows up on a list of Biotech Stocks Loved and Hated by the Pros in the most recently reported quarter.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
GEVA $238.60 1.19%
CASY $112.08 -1.50%
COST $147.84 -2.42%
MA $96.20 -0.05%
MDVN $59.40 0.58%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs